[go: up one dir, main page]

MXPA02010724A - Composicion para reducir la irritacion enzimatica de la piel. - Google Patents

Composicion para reducir la irritacion enzimatica de la piel.

Info

Publication number
MXPA02010724A
MXPA02010724A MXPA02010724A MXPA02010724A MXPA02010724A MX PA02010724 A MXPA02010724 A MX PA02010724A MX PA02010724 A MXPA02010724 A MX PA02010724A MX PA02010724 A MXPA02010724 A MX PA02010724A MX PA02010724 A MXPA02010724 A MX PA02010724A
Authority
MX
Mexico
Prior art keywords
composition
skin
irritation
reducing enzymatic
enzymes
Prior art date
Application number
MXPA02010724A
Other languages
English (en)
Inventor
Mcculloch Laura
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA02010724A publication Critical patent/MXPA02010724A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe una composicion que es util para reducir la irritacion de la piel provocada por enzimas; la composicion contiene una arcilla hinchable que tiene capas en una estructura de reticulo y un agente formador de peptidos, la composicion puede ser una suspension solida, coloidal, o formulacion en emulsion; tambien se describen metodos para tratar la piel para reducir o evitar la irritacion provocada por enzimas.
MXPA02010724A 2001-11-01 2002-10-30 Composicion para reducir la irritacion enzimatica de la piel. MXPA02010724A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/035,454 US20030104019A1 (en) 2001-11-01 2001-11-01 Composition for reducing enzymatic irritation to skin

Publications (1)

Publication Number Publication Date
MXPA02010724A true MXPA02010724A (es) 2004-09-03

Family

ID=21882770

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010724A MXPA02010724A (es) 2001-11-01 2002-10-30 Composicion para reducir la irritacion enzimatica de la piel.

Country Status (5)

Country Link
US (2) US20030104019A1 (es)
BR (1) BR0204573A (es)
CO (1) CO5390068A1 (es)
DE (1) DE10250600A1 (es)
MX (1) MXPA02010724A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943197B2 (en) * 2002-06-21 2005-09-13 Howard I. Maibach Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
US7858836B2 (en) * 2004-12-27 2010-12-28 Convatec Technologies Inc. Enzyme inhibiting adhesives
NZ547991A (en) * 2005-06-22 2008-08-29 Bristol Myers Squibb Co Enzyme inhibiting sprayable skin barrier compositions comprising enzyme inhibitors derived from potatoes
US20080103459A1 (en) 2006-10-30 2008-05-01 Anthony Di Salvo Enzyme inhibition using nanoparticles
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
ES2315200B1 (es) * 2007-09-14 2009-10-29 Clayspray, S.L. Composicion cosmetica para administracion topica en forma de spray.
US20090324506A1 (en) * 2008-06-30 2009-12-31 Jeffery Richard Seidling Sprayable skin protectant formulation and method of use
FR2937883A1 (fr) * 2008-10-31 2010-05-07 Mexel Ind Emulsion huile dans eau ou eau dans l'huile, liquide et stable, a base d'huiles vegetales ou minerales.
US20100286016A1 (en) * 2010-04-01 2010-11-11 KLC Brands, Inc. Non-V.O.C. sprayable gel to remove insect bodies-environmentally friendly
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087555A (en) * 1975-09-08 1978-05-02 Helena Rubinstein, Inc. Skin cream containing milk protein
FR2349336A1 (fr) * 1976-04-26 1977-11-25 Fellows Adrian Preparations desinfectantes et sterilisantes a base d'un di-aldehyde
GB8518910D0 (en) * 1985-07-26 1985-09-04 Procter & Gamble Ltd Toilet compositions
FR2651125B1 (fr) * 1989-08-23 1992-10-02 Roussel Uclaf Compositions pharmaceutiques de type "pates a l'eau".
US5114893A (en) * 1990-11-15 1992-05-19 American Colloid Company Method of improving water-swellable clay properties by re-drying, compositions and articles
US5436007A (en) * 1992-10-23 1995-07-25 Abbott Laboratories Diaper rash lotion
US5407879A (en) * 1993-09-29 1995-04-18 American Colloid Company Method of improving the contaminant resistance of a smectite clay by rewetting and impregnating the clay with a water-soluble polymer, and redrying the polymer-impregnated clay
CO5150202A1 (es) * 1998-12-31 2002-04-29 Kimberly Clark Co Composicion de tisu facial y metodo para usarla para el secuestro de irritantes de la piel de la secrecion nasal

Also Published As

Publication number Publication date
CO5390068A1 (es) 2004-04-30
DE10250600A1 (de) 2003-07-03
US20030104019A1 (en) 2003-06-05
US20050202056A1 (en) 2005-09-15
BR0204573A (pt) 2003-09-16

Similar Documents

Publication Publication Date Title
MXPA02010724A (es) Composicion para reducir la irritacion enzimatica de la piel.
MX2007006866A (es) Composiciones que tiene una alta eficacia antiviral y antibacterial.
WO2002091999A3 (en) Treatment for wounds
AU3104301A (en) Compositions and methods to effect the release profile in the transdermal administration of active agents
WO2001070132A3 (en) Injectable and swellable microspheres for dermal augmentation
NO20020299D0 (no) Behandling og sammensetning for oppnåelse av antialdring av hud med Corneum Protease aktivering
WO2005025522A3 (en) Skin care composition
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
AU2838101A (en) Use of melatonin for treating androgenetic and diffuse alopecia
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
EP1178796A4 (en) AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE
AU5170400A (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
PL378325A1 (pl) Kompozycja do stosowania miejscowego i sposoby leczenia skóry starzejącej się lub uszkodzonej przez środowisko
PL340467A1 (en) Application of mithrazapin in treating apnoea dissomnia
AU2002219804A1 (en) Water-in-oil insect repellent composition and method of application to the skin
AU7271300A (en) Particles for liquid compositions
WO2001076593A3 (en) Bile secretion promoting composition a 15-keto prostaglandin
EP1420743A4 (en) CHOLESTEROL SULFATE AND AMINO SUGAR COMPOSITIONS FOR IMPROVING THE FUNCTION OF THE CORNEO LAYER OF EPIDERMA
CO5550427A2 (es) Reduccion del crecimiento del vello
ATE323464T1 (de) Verwendung des dheas oder bestimmte seiner derivaten zur verbesserung des papyrus-ähnliches aussehens der haut
BRPI0517245A (pt) suspensão farmacêutica e de acetaminofeno isentas de corantes
NO994692D0 (no) Emulgert geleringsmiddel
EP1086933A3 (en) Cement composition
WO2002045704A3 (en) Prevention and treatment of tachyphylactic response